Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.
Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory for Blood Cell Research, Amsterdam, Netherlands.
Front Immunol. 2022 Mar 24;13:851868. doi: 10.3389/fimmu.2022.851868. eCollection 2022.
Since multiple different T-cell receptor (TCR) sequences can bind to the same peptide-MHC combination and the number of TCR-sequences that can theoretically be generated even exceeds the number of T cells in a human body, the likelihood that many public identical (PUB-I) TCR-sequences frequently contribute to immune responses has been estimated to be low. Here, we quantitatively analyzed the TCR-repertoires of 190 purified virus-specific memory T-cell populations, directed against 21 epitopes of Cytomegalovirus, Epstein-Barr virus and Adenovirus isolated from 29 healthy individuals, and determined the magnitude, defined as prevalence within the population and frequencies within individuals, of PUB-I TCR and of TCR-sequences that are highly-similar (PUB-HS) to these PUB-I TCR-sequences. We found that almost one third of all TCR nucleotide-sequences represented PUB-I TCR amino-acid (AA) sequences and found an additional 12% of PUB-HS TCRs differing by maximally 3 AAs. We illustrate that these PUB-I and PUB-HS TCRs were structurally related and contained shared core-sequences in their TCR-sequences. We found a prevalence of PUB-I and PUB-HS TCRs of up to 50% among individuals and showed frequencies of virus-specific PUB-I and PUB-HS TCRs making up more than 10% of each virus-specific T-cell population. These findings were confirmed by using an independent TCR-database of virus-specific TCRs. We therefore conclude that the magnitude of the contribution of PUB-I and PUB-HS TCRs to these virus-specific T-cell responses is high. Because the T cells from these virus-specific memory TCR-repertoires were the result of successful control of the virus in these healthy individuals, these PUB-HS TCRs and PUB-I TCRs may be attractive candidates for immunotherapy in immunocompromised patients that lack virus-specific T cells to control viral reactivation.
由于多个不同的 T 细胞受体(TCR)序列可以与同一肽-MHC 复合物结合,并且理论上可以产生的 TCR 序列数量甚至超过人体内的 T 细胞数量,因此许多公共相同(PUB-I)TCR 序列频繁参与免疫反应的可能性被估计很低。在这里,我们定量分析了来自 29 名健康个体的 21 个巨细胞病毒、EB 病毒和腺病毒表位的 190 个纯化的病毒特异性记忆 T 细胞群体的 TCR 谱,并确定了 PUB-I TCR 的数量,定义为群体内的流行率和个体内的频率,以及与这些 PUB-I TCR 序列高度相似(PUB-HS)的 TCR 序列的数量。我们发现,所有 TCR 核苷酸序列中有近三分之一代表 PUB-I TCR 氨基酸(AA)序列,并发现了另外 12%的 PUB-HS TCR 序列在最多 3 个 AA 处存在差异。我们说明这些 PUB-I 和 PUB-HS TCR 是结构相关的,并且在其 TCR 序列中包含共享的核心序列。我们发现个体中 PUB-I 和 PUB-HS TCR 的流行率高达 50%,并显示病毒特异性 PUB-I 和 PUB-HS TCR 的频率构成每个病毒特异性 T 细胞群体的 10%以上。这些发现通过使用独立的病毒特异性 TCR 数据库得到了证实。因此,我们得出结论,PUB-I 和 PUB-HS TCR 对这些病毒特异性 T 细胞反应的贡献程度很高。由于这些病毒特异性记忆 TCR 谱中的 T 细胞是这些健康个体成功控制病毒的结果,因此这些 PUB-HS TCR 和 PUB-I TCR 可能是免疫功能低下患者免疫治疗的有吸引力的候选物,这些患者缺乏控制病毒重新激活的病毒特异性 T 细胞。